HYPOCRATE
ActiveSummary
HYPOCRATE has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €180,016 and a net result of €33,438. Equity is growing by about 53% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Equity
- €180,016
- Profit
- €33,438
Why 94raises riskFounded in 2022lowers riskSize: total assets €238,247Liquidity: current ratio 2.96, cash €156,697Equity €180,016 (75.6% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 83% on liquidity, 69% on profitability and 78% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 3 accounts on average 15 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Equity above €150,000equity €180,016 ▲22.8%
- Annual accounts filedfinancial year 2024 · micro…
Financials · financial year 2025, micro format
2025 annual accounts filed late (20 days) Filed on 20 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00414417.
2023 to 2025, 3 financial years
The operating result falls in 2025; 2025 is 71% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,256 | €13,739 | €21,746 | ▲ 58.3% |
| Other operating charges640/8 | €348 | €5,638 | €782 | ▼ 86.1% |
| Gross operating margin9900 | €32,283 | €177,725 | €68,299 | ▼ 61.6% |
| Operating profit (loss)9901 | €25,680 | €158,349 | €45,771 | ▼ 71.1% |
| Financial income75/76B | - | €16 | €2 | ▼ 90.4% |
| Recurring financial income75 | - | €16 | €2 | ▼ 90.4% |
| Financial charges65/66B | €342 | €59 | €54 | ▼ 9.3% |
| Recurring financial charges65 | €342 | €59 | €54 | ▼ 9.3% |
| Profit (loss) for the period before taxes9903 | €25,338 | €158,305 | €45,719 | ▼ 71.1% |
| Income taxes67/77 | €5,000 | €36,065 | €12,281 | ▼ 65.9% |
| Profit (loss) for the period9904 | €20,338 | €122,240 | €33,438 | ▼ 72.6% |
| Profit (loss) for the period to be appropriated9905 | €20,338 | €122,240 | €33,438 | ▼ 72.6% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €29,765 | €188,342 | €238,247 | ▲ 26.5% |
| Fixed assets21/28 | €13,985 | €80,851 | €74,169 | ▼ 8.3% |
| Tangible fixed assets22/27 | €13,985 | €80,851 | €74,169 | ▼ 8.3% |
| Plant, machinery and equipment23 | €3,020 | €2,265 | €11,267 | ▲ 397% |
| Furniture and vehicles24 | €7,805 | €76,080 | €61,050 | ▼ 19.8% |
| Other tangible fixed assets26 | €3,160 | €2,506 | €1,852 | ▼ 26.1% |
| Current assets29/58 | €15,780 | €107,491 | €164,078 | ▲ 52.6% |
| Amounts receivable within one year40/41 | - | €224 | €3,247 | ▲ 14× |
| Other amounts receivable41 | - | €224 | €3,247 | ▲ 14× |
| Cash at bank and in hand54/58 | €14,598 | €87,948 | €156,697 | ▲ 78.2% |
| Deferred charges and accrued income490/1 | €1,182 | €19,318 | €4,134 | ▼ 78.6% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €29,765 | €188,342 | €238,247 | ▲ 26.5% |
| Equity10/15 | €24,338 | €146,578 | €180,016 | ▲ 22.8% |
| Contributions10/11 | €4,000 | €4,000 | €4,000 | = |
| Profit (loss) carried forward14 | €20,338 | €142,578 | €176,016 | ▲ 23.5% |
| Amounts payable17/49 | €5,427 | €41,764 | €58,231 | ▲ 39.4% |
| Amounts payable within one year42/48 | €5,087 | €41,764 | €55,478 | ▲ 32.8% |
| Trade debts44 | - | €944 | €7,459 | ▲ 690% |
| Suppliers440/4 | - | €944 | €7,459 | ▲ 690% |
| Taxes, remuneration and social security45 | €5,000 | €40,820 | €48,019 | ▲ 17.6% |
| Taxes450/3 | €5,000 | €40,820 | €48,019 | ▲ 17.6% |
| Other amounts payable47/48 | €87 | - | - | - |
| Accrued charges and deferred income492/3 | €340 | - | €2,754 | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €20,338 | €122,240 | €33,438 | ▼ 72.6% |
| + Depreciation and write-downs630 | €6,256 | €13,739 | €21,746 | ▲ 58.3% |
| Operating cash flow (approximation) | €26,594 | €135,979 | €55,184 | ▼ 59.4% |
| Investment in fixed assets (approximation) | - | -€80,605 | -€15,064 | ▲ 81.3% |
| Change in cash | - | €73,350 | €68,749 | ▼ 6.3% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (3)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 20-08-2026 | 2026-00414417 |
| 31-12-2024 | micro format | 30-07-2025 | 2025-00351077 |
| 31-12-2023 | micro format | 27-08-2024 | 2024-00398051 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| Dr. KANFAOUI Youness |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
History
Acts, filings and financial milestones
05-10
Gazette deed
IncorporationAppointment: KANFAOUI Youness (director) · Founder · Founding capital8 facts ▸
- Incorporation, 21-09-2022
- Founder, KANFAOUI Youness
- Other provision, “établissement des statuts, comparants” (deed in French)
- Founding capital
- Other provision, “dispositions finales et transitoires, unanimité des comparants” (deed in French)
- Registered office clause, “Rue de Liverpool,37 à 1080 Molenbeek-Saint-Jean” (deed in French)
- Director appointment, KANFAOUI Youness (director (not named in the articles))
- Pre-incorporation commitments, “takeover, l'un ou l'autre des comparants” (deed in French)
Register details
No listing in the Peppol Directory under this enterprise or VAT number. That proves nothing: being listed there is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance
If you follow this company, Checked tells you the day it appears in the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
2 establishment units
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21308H0508/00X005 | Brussels | 310 m² | 1 · 89 m² | 16.8 m · 4 |
| 21523B0945/00P005 | Brussels | 120 m² | 1 · 203 m² | 18.7 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “L’exercice de l’Art de guérir,et notamment la médecine spécialisée ou toute autre discipline apparentée,par le ou les médecins qui la…” (deed in French)
14 activities (deed in French)
- L’exercice de l’Art de guérir,et notamment la médecine spécialisée ou toute autre discipline apparentée,par le ou les médecins qui la composent lesquels sont exclusivement des médecins habilités à exercer l’Art de guérir en Belgique inscrits au Tableau de l’Ordre des médecins.
- Cet objet comprend la mise à disposition des moyens nécessaires aux médecins pour exercer leur art au sein de la société.
- La société pourra procéder à toutes les recherches et toutes études en rapport avec son objet principal,s’occuper de la recherche et du développement de techniques scientifiques favorisant un diagnostic précis.
- La société pourra,tant en Belgique qu’à l’étranger,exercer toute autre activité susceptible de favoriser son objet social tant de manière indépendante que dans le cadre de contrats avec des établissements de soins ou des confrères médecins,dans le respect du Code de déontologie médicale.
- La société pourra également s’intéresser de toutes façons dans toutes sociétés ou entreprises existantes ou à créer,dont l’objet serait similaire,analogue ou connexe au sien.
- La société pourra,pour son propre compte,réaliser toutes les opérations relatives à la gestion de son patrimoine privé,et notamment la construction,l’aménagement,la décoration,la vente,l’achat,la gestion,la location sous toute ses formes dont l’emphytéose de tous immeubles et des meubles qui les garnissent et la mise en valeur de tous les biens immobiliers ainsi que des activités de promotion et de transformations immobilières,en général,notamment pour héberger des activités médicales et dentaires dans l’optique d’une création d’une clinique qu’elle pourra également gérer en respectant la déontologie médicale.
- La société pourra exercer toute activité se rapportant directement ou indirectement à la conception,l’installation,le fonctionnement et l’organisation d’un centre de dispensation de soins,comprenant notamment la gestion et l’équipement d’un ou plusieurs centres médicaux en ce qui compris l’acquisition,la location,l’entretien de locaux,de matériel médical et de biens d’équipements,et en général la mise à disposition de tout ce qui nécessaire et utile à la pratique de l’art de guérir.
- La société pourra faire tout acte nécessaire et/ou indispensable à l’accomplissement de son objet et plus particulièrement toute transaction mobilière ou immobilière concernant les locaux médicaux,l’achat du matériel médical et non médical,l’engagement du personnel administratif,soignant,pratiquant ou appelé à pratiquer dans la société.
- La société pourra d’une façon générale accomplir toutes opérations se rapportant directement ou indirectement à la réalisation de son objet social,sans en modifier le caractère civil et la vocation médicale.
- A titre accessoire,la société aura également pour objet la constitution,notamment au départ de ses bénéfices réservés,la gestion et la valorisation d’un patrimoine immobilier ou mobilier,notamment par l’achat,la vente,la location,la mise en location,la construction,le tout au sens le plus large.
- Elle dispose,d’une manière générale,d’une pleine capacité juridique pour accomplir tous les actes et opérations ayant un rapport direct ou indirect avec son objet ou qui seraient de nature à faciliter directement ou indirectement,entièrement ou partiellement,la réalisation de cet objet.
- Elle peut s’intéresser par voie d’association,d’apport,de fusion,d’intervention financière ou autrement dans toutes sociétés,associations ou entreprises dont l’objet est identique,analogue ou connexe au sien ou susceptible de favoriser le développement de son entreprise ou de constituer pour elle une source de débouchés.
- Elle peut exercer les fonctions d’administrateur ou liquidateur dans d’autres sociétés.
- La société peut se porter garant ou fournir des sûretés réelles pour des sociétés ou des personnes privées,au sens le plus large.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- HYPOCRATE
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles-Capitale, Conseil provincial de l’Ordre des Médecins” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “1” (deed in French)“Par assemblée fixe nombre durée pouvoirs, un ou plusieurs administrateurs personnes physiques ou morales actionnaires ou non” (deed in French)“Prestations administration ou gestion réellement effectuées, frais généraux indépendamment frais représentation voyages déplacements” (deed in French)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement actions si plusieurs, adressée à organe d'administration sous pli recommandé” (deed in French)
- Share issue ruleHow and by whom new shares can be issued.
- “Actions nouvelles à souscrire en numéraire, courrier électronique,ou courrier ordinaire même jour si sans adresse électronique” (deed in French)
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Formes prévues pour les modifications aux statuts, en tout temps” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Dissolution pour quelque cause et à quelque moment que ce soit, désigner un ou plusieurs liquidateurs et déterminer pouvoirs et émoluments” (deed in French)